Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yutang Li

Showing results (31-40 of 50) with videos related to

Pageof 5
Sort By:
Signal Transduction and Targeted Therapy|May 19, 2021
Ceftazidime is a potential drug to inhibit SARS-CoV-2 infection in vitro by blocking spike protein-ACE2 interactionChangDong Lin, Yue Li, YueBin Zhang, et al.
Optics Express|February 20, 2026
Enhanced Doppler tomography LiDAR imaging using the MACE framework and deep denoisersYutang Li, Dengfeng Liu, Xiaohua Feng, et al.
Signal Transduction and Targeted Therapy|June 11, 2021
Correction To: Ceftazidime is a potential drug to inhibit SARS-CoV-2 infection in vitro by blocking spike protein-ACE2 interactionChangDong Lin, Yue Li, YueBin Zhang, et al.
Bioscience Reports|December 1, 2017
Zhenbao pill protects against acute spinal cord injury via <i>miR-146a-5p</i> regulating the expression of GPR17Yongxiong He, Bokang Lv, Yanqiang Huan, et al.
ACS Nano|February 9, 2024
Boosting Sono-immunotherapy of Prostate Carcinoma through Amplifying Domino-Effect of Mitochondrial Oxidative Stress Using Biodegradable Cascade-Targeting NanocompositesYandong Wang, Haodong Li, Guiming Niu, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|January 16, 2017
The nucleotide changes within HBV core promoter/precore during the first 12weeks of nucleos(t)ide treatment might be associated with a better virological responseYaqin Peng, Yutang Li, Jinlin Hou, et al.
Burns : Journal of the International Society for Burn Injuries|October 15, 2025
Skin microbiota, immune phenotypes, inflammatory response and hypertrophic scars: A Mendelian randomization studyYutang Li, Li Tang, Yiyi He, et al.
Journal of Clinical Microbiology|July 28, 2017
Serum Hepatitis B Virus DNA, RNA, and HBsAg: Which Correlated Better with Intrahepatic Covalently Closed Circular DNA before and after Nucleos(t)ide Analogue Treatment?Yuhua Gao, Yutang Li, Qinghua Meng, et al.
Infection and Drug Resistance|October 17, 2018
Characteristics of HBV infection in 705 HIV-infected patients under lamivudine-based antiretroviral treatment from three regions in ChinaMingze Su, Lingjie Liao, Hui Xing, et al.
International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience|May 15, 2018
Gene analysis: A rare gene disease of intellectual deficiency-Cohen syndromeChengqing Yang, Mei Hou, Yutang Li, et al.
Pageof 5

Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
Signal Transduction and Targeted Therapy|May 19, 2021
Ceftazidime is a potential drug to inhibit SARS-CoV-2 infection in vitro by blocking spike protein-ACE2 interactionChangDong Lin, Yue Li, YueBin Zhang, et al.
Optics Express|February 20, 2026
Enhanced Doppler tomography LiDAR imaging using the MACE framework and deep denoisersYutang Li, Dengfeng Liu, Xiaohua Feng, et al.
Signal Transduction and Targeted Therapy|June 11, 2021
Correction To: Ceftazidime is a potential drug to inhibit SARS-CoV-2 infection in vitro by blocking spike protein-ACE2 interactionChangDong Lin, Yue Li, YueBin Zhang, et al.
Bioscience Reports|December 1, 2017
Zhenbao pill protects against acute spinal cord injury via <i>miR-146a-5p</i> regulating the expression of GPR17Yongxiong He, Bokang Lv, Yanqiang Huan, et al.
ACS Nano|February 9, 2024
Boosting Sono-immunotherapy of Prostate Carcinoma through Amplifying Domino-Effect of Mitochondrial Oxidative Stress Using Biodegradable Cascade-Targeting NanocompositesYandong Wang, Haodong Li, Guiming Niu, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|January 16, 2017
The nucleotide changes within HBV core promoter/precore during the first 12weeks of nucleos(t)ide treatment might be associated with a better virological responseYaqin Peng, Yutang Li, Jinlin Hou, et al.
Burns : Journal of the International Society for Burn Injuries|October 15, 2025
Skin microbiota, immune phenotypes, inflammatory response and hypertrophic scars: A Mendelian randomization studyYutang Li, Li Tang, Yiyi He, et al.
Journal of Clinical Microbiology|July 28, 2017
Serum Hepatitis B Virus DNA, RNA, and HBsAg: Which Correlated Better with Intrahepatic Covalently Closed Circular DNA before and after Nucleos(t)ide Analogue Treatment?Yuhua Gao, Yutang Li, Qinghua Meng, et al.
Infection and Drug Resistance|October 17, 2018
Characteristics of HBV infection in 705 HIV-infected patients under lamivudine-based antiretroviral treatment from three regions in ChinaMingze Su, Lingjie Liao, Hui Xing, et al.
International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience|May 15, 2018
Gene analysis: A rare gene disease of intellectual deficiency-Cohen syndromeChengqing Yang, Mei Hou, Yutang Li, et al.
Pageof 5